Enovix Founder-CEO Exits as Smartphone Qualification Nears
Enovix (ENVX) reaffirmed third-quarter revenue guidance of $9.0 million to $10.0 million even as it disclosed the abrupt departure of Chief Executive Raj Talluri.
Enovix (ENVX) reported that Raj Talluri resigned as chief executive effective August 13, 2026, with the board naming Chief Financial Officer Ryan Benton interim CEO and Chairman T.J. Rodgers executive chairman. The battery maker paired the leadership change with a reaffirmation of third-quarter revenue guidance of $9.0 million to $10.0 million, implying growth of 13% to 25% from a year earlier and leaving the outlook first issued alongside second-quarter results unchanged.
The continuity in guidance matters because the underlying growth rate has been slowing. Second-quarter revenue reached $9.0 million, up 21% from a year earlier and 19% from the first quarter's $7.6 million, extending Enovix's streak of year-over-year revenue growth to five straight quarters. That 21% expansion trailed the first quarter's 49% pace, a deceleration that coincided with margin pressure: GAAP gross margin fell to 14.4% and non-GAAP gross margin to 19.9%, down 11.6 and 10.9 percentage points from a year earlier, which Enovix attributed to a shift in battery product mix. Gross profit stayed positive for a seventh consecutive quarter, and the GAAP net loss narrowed slightly to $0.20 a share from $0.22.
The mix shift traces to a defense and drone business that has become the company's dominant revenue source. Defense and drone sales made up 65% of second-quarter revenue, a figure not broken out in the earnings release itself. The pipeline behind that business grew to $183 million as of the second quarter, up 41% from $130 million at the end of the first quarter, with drone opportunities alone exceeding $100 million. Enovix has also moved to concentrate operational control over that scale-up: Chief Operating Officer Michael Vyvoda's mandate, expanded from manufacturing, supply chain and operations engineering when he took the COO role in July, now covers equipment engineering end-to-end and absorbs the 80-person R&D group.
Alongside the defense ramp, Enovix pointed to progress on the smartphone qualification that has anchored its long-term case. Its lead smartphone customer passed more than 1,000 cycles under a 0.2C discharge test, a milestone announced August 12 that moves beyond the first quarter's language of testing "approaching performance thresholds" without a specific cycle count. The anchor release repeated management's characterization of the milestone as the "event of the decade," even as the final accelerated cycle-life test needed to complete qualification remains underway, with Enovix maintaining its fourth-quarter 2026 completion target unchanged from the prior release. A second smartphone OEM has also moved further along: after describing that customer in the first quarter as still discussing a replacement qualification framework, Enovix said in the second quarter that the customer is progressing toward alignment, with sample deliveries expected to begin in the fourth quarter.
Enovix also introduced a new competitive marker in the anchor release, saying it now ships anodes with 100% silicon content while no other manufacturer exceeds 32%, a comparison not included in prior quarterly releases. The company's smart eyewear program showed a similar acceleration: after shipping early production units with no revenue in the first quarter, Enovix shipped roughly 2,100 AI-1 packs in the second quarter and recognized initial revenue from them, and it guided third-quarter shipments to rise roughly ninefold to about 19,000 packs against a 50,000-pack order.
Enovix ended the second quarter with roughly $552.1 million in cash, cash equivalents and marketable securities, including restricted cash, though the anchor release did not update that figure. With the CEO transition unresolved and cash last reported six weeks earlier, the pace at which Benton and Rodgers execute the smartphone qualification timeline through year-end stands as the clearest near-term test of the reaffirmed guidance.